Skip to main content
OpenTrials

Clinical trial condition

Salivary Gland Neoplasms

Explore clinical trials studying Salivary Gland Neoplasms. Study availability and eligibility vary by location and protocol.

190 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Salivary Gland Neoplasms trial results

Recruiting

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

NCT03556228

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +65 more
Locations
  • Providence Medical Foundation (site 209) Santa Rosa, California, United States
  • Hartford Hospital (site 210) Hartford, Connecticut, United States
  • The George Washington University Cancer Center (site 212) Washington D.C., District of Columbia, United States
  • Holy Cross Hospital (site 213) Fort Lauderdale, Florida, United States
View all 15 locations
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations

NCT05786716

Conditions
Adnexal Diseases, Biliary Tract Diseases, Biliary Tract Neoplasms, +61 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details
Recruiting

Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants

NCT00898638

Conditions
Carcinoma, Carcinoma, Squamous Cell, Cranial Nerve Diseases, +22 more
Locations
  • Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States
  • Veterans Affairs Medical Center - Nashville Nashville, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Recruiting

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

NCT05941507

Conditions
Adnexal Diseases, Advanced Solid Tumors, Anus Diseases, +60 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Tennessee Oncology Nashville, Tennessee, United States
View Trial Details

Related conditions